Pharmacogenetics of telatinib, a VEGFR-2 and VEGFR-3 tyrosine kinase inhibitor, used in patients with solid tumors

Purpose Telatinib is an orally active small-molecule tyrosine kinase inhibitor of kinase insert domain receptor (KDR; VEGFR-2) and fms-related tyrosine kinase 4 (FLT4; VEGFR-3). This study aims at the identification of relationships between single nucleotide polymorphisms (SNPs) in genes encoding fo...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Steeghs, Neeltje, Gelderblom, Hans, Wessels, Judith, Eskens, Ferry A. L. M., de Bont, Natasja, Nortier, Johan W. R., Guchelaar, Henk-Jan
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer US 2009
Soggetti:
Phase I Studies
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3016151/
https://ncbi.nlm.nih.gov/pubmed/19924384
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10637-009-9347-0
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi